North America’s medical devices industry saw a drop of 22.52% in deal activity during August 2022, when compared with the last 12-month average, led by Teleflex’s $300m acquisition of Standard Bariatrics, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 86 medical devices industry deals worth $1.4bn were announced for the region in August 2022, against the 12-month average of 111 deals.
Of all the deal types, venture financing saw most activity in August 2022 with 68 transactions, representing a 79.1% share for the region.
In second place was M&A with 16 deals, followed by private equity deals with two transactions, respectively capturing an 18.6% and 2.3% share of the overall deal activity for the month.
In terms of value of deals, venture financing was the leading category in North America’s medical devices industry with $839.37m, while M&A and private equity deals totalled $552m and $7.25m, respectively.
North America medical devices industry deals in August 2022: Top deals
The top five medical devices deals accounted for 55.4% of the overall value during August 2022.
The combined value of the top five medical devices deals stood at $775m, against the overall value of $1.4bn recorded for the month.
The top five medical devices industry deals of August 2022 tracked by GlobalData were:
1) Teleflex’s $300m acquisition deal with Standard Bariatrics
2) The $250m acquisition of Biorez by ConMed
3) Andera Partners, Bain Capital Life Sciences, Cormorant Asset Management, Gimv, Innovatus Capital Partners, Peijia Medical, Pictet Alternative Advisors, Qatar Investment Authority, RMM Consulting Group, Valiance Advisors and Venture Incubator’s $100m venture financing deal with JenaValve Technology
4) The $75m venture financing of Digital Diagnostics by Cedar Pine, Edward-Elmhurst Health Venture Capital, Eight Partners, Gundersen Health System, Kinderhook Industries, KKRInc, Optum Ventures, OSF Ventures and University of Iowa
5) Novo Holdings’s $50m venture financing deal with MedGenome
